Track tremor severity over time

Trial ID
NCT05066763
Official Title
Parkinson's Foundation Surveys
Goal
Track tremor severity over time
Status
RECRUITING
Sponsor
Parkinson's Foundation
Study Type
OBSERVATIONAL
Enrollment
1000000 participants
Conditions
Parkinson Disease
Interventions
Non-interventional

Summary For Families

The goal is to collect real-world experiences from people affected by Parkinson's so the Parkinson's Foundation can identify unmet needs, shape future research priorities, and improve programs and services. The approach is non-interventional surveys, asking people with Parkinson's, their care partners, and clinicians about symptoms, treatments, daily challenges, and research interests, and the aggregated answers are used to guide funding decisions and the design of future studies. Anyone 18 or older who self-reports a Parkinson's diagnosis, is a care partner for someone with Parkinson's, or is a health professional who regularly works with people with Parkinson's, and who is willing to be contacted, is eligible to participate.

Locations

  • Parkinson's Foundation, Miami, Florida, United States

Frequently Asked Questions

What is this trial testing?
This trial is studying Non-interventional. The goal is to collect real-world experiences from people affected by Parkinson's so the Parkinson's Foundation can identify unmet needs, shape future research priorities, and improve programs and services. The approach is non-interventional surveys, asking people with Parkinson's, their care partners, and clinicians about symptoms, treatments, daily challenges, and research interests, and the aggregated answers are used to guide funding decisions and the design of future studies. Anyone 18 or older who self-reports a Parkinson's diagnosis, is a care partner for someone with Parkinson's, or is a health professional who regularly works with people with Parkinson's, and who is willing to be contacted, is eligible to participate.
Who can participate?
Participants must be at least 18 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 9 years and 8 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov